Intemalisation of isotope-coupled somatostatin analogues

Digestion

Volumn 57, Issue , 1996, Pages 2-6

  Hofland, L J ^a   Van Koetsveld, P M ^a   Waaijers, M ^a   Lamberts, S W J ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Human; Mouse; Octreotide; Pituitary; Scintigraphy; Sst; Tumour

Indexed keywords

INDIUM 111; OCTREOTIDE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

BINDING AFFINITY; CONFERENCE PAPER; CULTURAL ANTHROPOLOGY; GOLGI COMPLEX; HUMAN; HYPOPHYSIS ADENOMA; INTERNALIZATION; LYSOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR SCINTISCANNING;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; HORMONE ANTAGONISTS; HUMANS; MICE; OCTREOTIDE; SOMATOSTATIN;

EID: 0029896839     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000201382     Document Type: Article

References (32)

1. Reubi JC, Laissuc J, Krenning E, Lamberts SWJ: Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol 1992;43:27-35.
2. Greenman Y, Melmcd S: Heterogeneous expression of two somatostatin receptor subtypes in pituitary' tumours. J Clin Endocrinol Metab 1994;78:398-403.
3. Greenman Y, Mclmed S: Expression of three somatostatin receptor subtypes in pituitary adenomas: Evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab 1994;79:724-729.
4. Reubi JC, Schaer JC, Wascr B, Mengod G: Expression and localization of somatostatin receptor SSTR1. SSTR2. and SSTR3 messenger RNAs in primary human tumours using in situ hybridization. Cancer Res 1994:54:3455-3459.
5. Panetta R, Patel YC: Expression of mRNA for all five human somatostatin receptors (hSSTRl-5) in pituitary tumours. Life Sei 1995;56:333-342.
6. Miller GM, Alexander JM, Bikkal HA, Katz-nclson L, Zervas NT, Klibansky A: Somatostatin receptor subtype gene expression in pituitary adenomas. J Clin Endocrinol Metab 1995;80:1386-1392.
7. Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, Imura H, Seino S, Seino Y: Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumours. J Clin Invest 1994;93:1321-1325.
8. Krcnning EP, Bakker WH, Brecman WAP, Koper JW, Kooij PPM, Ausema L, Lameris JS, Lamberts SWJ: Localization of endocrine-related tumours with radioiodinated analogue of somatostatin. Lancet 1989;i:242-244.
9. l23I-Tyr'j-octrcotide: The Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
10. Lamberts SWJ, Krenning EP, Reubi JC: The role of somatostatin and its analogues in the diagnosis and treatment of tumours. Endocr Rev 1991;12:450-482.
11. mIn-DTPA-/5-Phc'joctrcotidc: A case history. Ann NY Acad Sci 1994;733:496-506.
12. Morel G, Mesguich P, Dubois MP, Dubois PM: Ultrastructural evidence for endogenous somatostatin-like immunoreactivity in the pituitary gland. Neuroendocrinology 1983:36: 291-299.
13. Draznin B, Sherman N, Sussman K, Dahl R, Vatter A: Internalization and cellular processing of somatostatin in primary cultures of rat anterior pituitary cells. Endocrinology 1985; 117:960-966.
14. Mentlcin R, Buchholz C, Krisch B: Binding and internalization of gold-conjugated somatostatin and growth hormone-releasing hormone in cultured rat somatotropes. Cell Tissue Res 1989;258:309-317.
15. Morel G, Pelletier G, Heisler S: Internalization and subcellular distribution of radiolabclled somatostatin-28 in mouse anterior pituitary tumour cells. Endocrinology 1986; 119:1972- 1979.
16. Morel G, Leroux P, Pelletier G: Ultrastructural autoradiographic localization of somatostatin-28 in the rat anterior pituitary gland. Endocrinology 1985:116:1615-1619.
17. Amherdt M, Patel YC, Orci L: Binding and internalization of somatostatin, insulin, and glucagon by cultured rat islet cells. J Clin Invest 1989:84:412-417.
18. Presky DH, Sehonbrunn A: Receptor-bound somatostatin and epidermal growth factor arc processed differently in GH4C1 rat pituitarv cells. J Cell Biol 1986;102:878-888.
19. “25I-Tyr"]somatostatin by RINm5F insulinoma cells. J Biol Chem 1986; 261:3571-3577.
20. Bruns C, Weckbecker G, Raulf F, Kaupmann K, Schoefftcr P, Hoyer D, Lubbert H: Molecular pharmacology of somatostatin-receptor sub-types. Ann NY Acad Sci 1994;733:138-146.
21. Hoyer D, Lubbcrt H, Bruns C: Molecular pharmacology of somatostatin receptors. Arch Pharmacol 1994;350:441-453.
22. Rcisinc T, Bell GI: Molecular biology of somatostatin receptors. Endocr Rev 1995:16:427- 442.
23. 3]octrcotide by mouse and human pituitary tumour cells: Increase by unlabelled octreotide. Endocrinology 1995; 136:3698-3706.
24. Patel YC, Panetta R, Escher E, Greenwood M, Srikant CB: Expression of multiple somatostatin receptor genes in AtT-20 cells. J Biol Chem 1994;269:1506-1509.
25. Hofland LJ, van Koetsveld PM, Wouters N, Waaijers M, Reubi JC, Lamberts SWJ: Dissociation of antiproliferative and antihormonal effecis of the somatostatin analogue octreotide on 7315b pituitary tumour cells. Endocrinology 1992;131:571-577.
26. Rcubi JC: New specific radioligand for one subpopulation of brain somatostatin receptors. Life Sci 1985;36:1829-1836.
27. Bauer W, Briner U, Doepfner W, Haller R, Huguenin R, Marbach P, Petcher TJ, Pless J: SMS201-995: A very potent and selectiveocta-pcptide analogue of SR1F' with prolonged action. Life Sci 1982;31:1133-1140.
28. Sussman KE, Mehler PS, Lcitner JW, Draznin B: Role of the secretion vesicle in the transport of receptors: Modulation of somatostatin binding to pancreatic islets. Endocrinology 1982: 111:316-323.
29. Bruno JF, Bcrelowitz M: Somatostatin regulates somatostatin receptor subtype mRNA expression in GHj cells. Biochem Biophvs Res Commun 1994;202:1738-1743.
30. Presky DH, Sehonbrunn A: Somatostatin pretreatment increases the number of receptors on GH4C1 pituitary' cells and does not reduce cellular responsiveness to somatostatin. J Bio! Chem 1988;263:714-721.
31. Srikant B, Heisler S: Relationship between receptor binding and biopotency of somatostatin-14 and somatostatin-28 in mouse pituitary tumour cells. Endocrinology 1985; 117:271- 278.
32. Mahy N, Woolkalis M, Manning D, Reisine T: Characteristics of somatostatin desensitization in the pituitary tumour cell line AtT-20. J Pharmacol ExpTher 1988:247:390-396.